TORRENT PHARMACEUTICALS
|
The Current P/E Ratio of TORRENT PHARMACEUTICALS is 57.59.
Share Price | ₹3,252.1 | Jun 17,2025 |
Market Cap | ₹110,051.1 Cr | |
Earnings-TTM | ₹1,911.0 Cr | TTM-Consolidated Results |
Price/Earnings | 57.59x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of TORRENT PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹110,051.1 Cr] as on Jun 17,2025
(/) Earnings [ ₹1,911.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 57.59x ]
Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay 57.59 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of TORRENT PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of TORRENT PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of TORRENT PHARMACEUTICALS
PE Ratio Performance Analysis for TORRENT PHARMACEUTICALS
- TORRENT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 31.77x.
- TORRENT PHARMACEUTICALS 's operated at median p/e ratio of 30.45x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 53.15x.
- TORRENT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 16.28x.
How does TORRENT PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
TORRENT PHARMACEUTICALS | 1,911.00 | 57.59 | 110,051.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.03 | 395,614.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 79.20 | 173,533.0 |
CIPLA LTD | 5,291.05 | 22.95 | 121,439.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 19.30 | 110,076.0 |
MANKIND PHARMA LTD | 2,003.22 | 48.47 | 97,090.3 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 20.91 | 96,487.8 |
LUPIN LTD | 3,306.26 | 26.84 | 88,756.5 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.33 | 64,439.9 |
ABBOTT INDIA LTD | 1,414.44 | 47.78 | 67,579.9 |
ALKEM LABORATORIES LTD | 2,216.00 | 25.97 | 57,542.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs TORRENT PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.33x |
Max industry PE | 79.20x |
Median industry PE | 26.84x |
Average industry PE | 36.67x |
You may also like the below Video Courses